Search results for "Primary prevention"
Stopping preventive aspirin associated with 37% increased risk of cardiovascular events
Patients who continued aspirin had a 4.1% yearly incidence of cardiovascular events, compared to 5.4% among those who stopped taking the drug, while the risk of discontinuation corresponded to one additional cardiovascular event for every 74 patients who stopped taking aspirin in a year.
https://immattersacp.org/weekly/archives/2017/10/03/4.htm
3 Oct 2017
Preventive aspirin inflames opinions
Aspirin's long-standing role in cardiovascular health does not resolve its precise benefit in terms of cardiovascular prevention, specifically in patients who haven't had a myocardial infarction or stroke.
https://immattersacp.org/archives/2015/05/aspirin.htm
1 May 2015
Guidance issued on nonstatin therapies for cholesterol lowering
The goal of the decision pathway was to provide practical guidance for clinicians and patients in situations not covered by the 2013 ACC/AHA guideline until new clinical guidelines on the topic are published.
https://immattersacp.org/weekly/archives/2016/04/05/4.htm
5 Apr 2016
Statin treatment reduced cardiovascular events more than hypertension drugs in intermediate-risk patients, study finds
An accompanying editorial said that the results of this trial support the benefits of statins for primary prevention and a risk-based approach to prescribing, rather than one based on LDL levels.
https://immattersacp.org/weekly/archives/2016/04/05/1.htm
5 Apr 2016
Minding your P's and M's
In medicine, internists need to mind not just their "P's and Q's" but their "P's and M's," that is, evidence-based practice and evidence-based medicine.
https://immattersacp.org/archives/2017/05/presidents.htm
1 May 2017
Medical therapy often not tried before ICDs in heart failure patients
Results of a trial suggest that at least some patients with heart failure are receiving ICDs needlessly and highlight the treatment gap between real-world management of heart failure with reduced ejection fraction and opportunities to improve care.
https://immattersacp.org/weekly/archives/2016/03/08/2.htm
8 Mar 2016
Different patients, different doses
Some patients may metabolize certain drugs differently, requiring primary care physicians to know any safety or dosing issues for the most commonly used drugs.
https://immattersacp.org/archives/2019/05/different-patients-different-doses.htm
1 May 2019
Calculating risk for cholesterol drugs
Differing guidelines and a new class of drugs may cause uncertainty on the part of patients and practitioners.
https://immattersacp.org/archives/2015/11/cholesterol.htm
1 Nov 2015
New assessment tool may improve predictions of CV risk, impact of preventive treatments
The new three-step tool aims to provide a framework for delivering appropriate risk-reducing strategies to Medicare patients with a 10-year atherosclerotic cardiovascular disease risk greater than 30%.
https://immattersacp.org/weekly/archives/2016/11/08/4.htm
8 Nov 2016
MKSAP Quiz: Cardiac risk assessment
A 58-year-old man is evaluated during a routine appointment and asks for advice on cardiac risk assessment. He does not have any current cardiac symptoms, exercises 4 days per week, and has never smoked. He has no chronic health issues and takes no medications. He has no known drug allergies. Results of the physical examination are normal. Following cardiovascular risk calculation, what test should be performed next?
https://immattersacp.org/weekly/archives/2016/04/05/3.htm
5 Apr 2016